Search Results

There are 15705 results for: content related to: Validation of a Screening Instrument for Nephrogenic Systemic Fibrosis

  1. Nephrogenic systemic fibrosis and the role of gadolinium contrast media

    Journal of Medical Imaging and Radiation Oncology

    Volume 52, Issue 4, August 2008, Pages: 339–350, AJ Van Der Molen

    Version of Record online : 16 SEP 2008, DOI: 10.1111/j.1440-1673.2008.01965.x

  2. You have free access to this content
    Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents

    International Journal of Urology

    Volume 19, Issue 9, September 2012, Pages: 806–811, Kazuhiro Kitajima, Tetsuo Maeda, Sanae Watanabe, Yoshiko Ueno and Kazuro Sugimura

    Version of Record online : 9 MAY 2012, DOI: 10.1111/j.1442-2042.2012.03042.x

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 19, Issue 12, 1127, Version of Record online: 26 NOV 2012

  3. Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agents

    Journal of Magnetic Resonance Imaging

    Volume 41, Issue 5, May 2015, Pages: 1259–1267, Emmanuil Smorodinsky, David S. Ansdell, Zeke W. Foster, Sameer M. Mazhar, Irene Cruite, Tanya Wolfson, Sebastian B. Sugay, Gabriella Iussich, Masoud Shiehmorteza, Yuko Kono, Alexander Kuo and Claude B. Sirlin

    Version of Record online : 9 MAY 2014, DOI: 10.1002/jmri.24650

  4. Nephrogenic systemic fibrosis: A case report and review on Japanese patients

    The Journal of Dermatology

    Volume 39, Issue 5, May 2012, Pages: 449–453, Yuka MATSUMOTO, Yoshihiko MITSUHASHI, Fumiko MONMA, Masakazu KAWAGUCHI, Tamio SUZUKI, Chie MIYABE, Atsuyuki IGARASHI and Ryoji TSUBOI

    Version of Record online : 31 OCT 2011, DOI: 10.1111/j.1346-8138.2011.01407.x

  5. Nephrogenic Systemic Fibrosis and Gadolinium-Containing Radiological Contrast Agents: An Update

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue 6, June 2011, Pages: 920–923, N Jalandhara, R Arora and V Batuman

    Version of Record online : 6 APR 2011, DOI: 10.1038/clpt.2010.346

  6. You have free access to this content
    Risk factors for NSF: A literature review

    Journal of Magnetic Resonance Imaging

    Volume 30, Issue 6, December 2009, Pages: 1298–1308, Martin R. Prince, Hong Lei Zhang, Giles H. Roditi, Tim Leiner and Walter Kucharczyk

    Version of Record online : 24 NOV 2009, DOI: 10.1002/jmri.21973

  7. You have free access to this content
    Cutaneous changes of nephrogenic systemic fibrosis: Predictor of early mortality and association with gadolinium exposure

    Arthritis & Rheumatism

    Volume 56, Issue 10, October 2007, Pages: 3433–3441, Derrick J. Todd, Anna Kagan, Lori B. Chibnik and Jonathan Kay

    Version of Record online : 28 SEP 2007, DOI: 10.1002/art.22925

  8. Time-dependent decrement of dermal gadolinium deposits and significant improvement of skin symptoms in a patient with nephrogenic systemic fibrosis after temporary renal failure

    Journal of Cutaneous Pathology

    Volume 40, Issue 11, November 2013, Pages: 935–944, Susanne G. Schäd, Peter Heitland, W. Nikolaus Kühn-Velten, Gerd E. Gross and Ludwig Jonas

    Version of Record online : 16 SEP 2013, DOI: 10.1111/cup.12214

  9. Nephrogenic systemic fibrosis, in patients with end-stage kidney disease on dialysis, in the greater Auckland region, from 2000–2006

    Nephrology

    Volume 16, Issue 2, February 2011, Pages: 243–248, JAMIE C KENDRICK-JONES, DAVID M VOSS and JANAK R DE ZOYSA

    Version of Record online : 27 JAN 2011, DOI: 10.1111/j.1440-1797.2010.01397.x

  10. You have free access to this content
    Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide

    British Journal of Pharmacology

    Volume 165, Issue 4b, February 2012, Pages: 1151–1162, N Fretellier, JM Idée, P Bruneval, S Guerret, F Daubiné, G Jestin, C Factor, N Poveda, A Dencausse, F Massicot, O Laprévote, C Mandet, N Bouzian, M Port and C Corot

    Version of Record online : 26 JAN 2012, DOI: 10.1111/j.1476-5381.2011.01585.x

  11. NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Patient Characteristics and Risk Factors for Nephrogenic Systemic Fibrosis Following Gadolinium Exposure

    Seminars in Dialysis

    Volume 21, Issue 2, March/April 2008, Pages: 135–139, Thomas Grobner and Friedrich C. Prischl

    Version of Record online : 23 JAN 2008, DOI: 10.1111/j.1525-139X.2007.00406.x

  12. Gadolinium-Induced Nephrogenic Systemic Fibrosis Is Associated with Insoluble Gd Deposits in Tissues: In Vivo Transmetallation Confirmed by Microanalysis

    Journal of Cutaneous Pathology

    Volume 36, Issue 12, December 2009, Pages: 1244–1254, Charu Thakral and Jerrold L. Abraham

    Version of Record online : 7 JUL 2009, DOI: 10.1111/j.1600-0560.2009.01283.x

  13. Nephrogenic systemic fibrosis is found only among gadolinium-exposed patients with renal insufficiency: a case–control study from Denmark

    British Journal of Dermatology

    Volume 165, Issue 4, October 2011, Pages: 828–836, T.R. Elmholdt, M. Pedersen, B. Jørgensen, K. Søndergaard, J.D. Jensen, M. Ramsing and A.B. Olesen

    Version of Record online : 27 SEP 2011, DOI: 10.1111/j.1365-2133.2011.10465.x

  14. Gadolinium and Nephrogenic Systemic Fibrosis: Have We Overreacted?

    Seminars in Dialysis

    Volume 24, Issue 5, September/October 2011, Pages: 480–486, Jeffrey G. Penfield and Robert F. Reilly

    Version of Record online : 13 SEP 2011, DOI: 10.1111/j.1525-139X.2011.00945.x

  15. You have free access to this content
    Nephrogenic systemic fibrosis: Clinical spectrum of disease

    Journal of Magnetic Resonance Imaging

    Volume 30, Issue 6, December 2009, Pages: 1289–1297, Michael Mayr, Felix Burkhalter and Georg Bongartz

    Version of Record online : 24 NOV 2009, DOI: 10.1002/jmri.21975

  16. Pathomechanisms of nephrogenic systemic fibrosis: new insights

    Clinical and Experimental Dermatology

    Volume 36, Issue 7, October 2011, Pages: 763–768, A. Gupta, M. K. Shamseddin and A. Khaira

    Version of Record online : 25 JUL 2011, DOI: 10.1111/j.1365-2230.2011.04136.x

  17. NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Nephrogenic Systemic Fibrosis: Early Recognition and Treatment

    Seminars in Dialysis

    Volume 21, Issue 2, March/April 2008, Pages: 123–128, Eleanor A. Knopp and Shawn E. Cowper

    Version of Record online : 23 JAN 2008, DOI: 10.1111/j.1525-139X.2007.00399.x

  18. You have free access to this content
    Incidence of nephrogenic systemic fibrosis at Chinese PLA General Hospital

    Journal of Magnetic Resonance Imaging

    Volume 30, Issue 6, December 2009, Pages: 1309–1312, Zhitong Zou, Lin Ma and Hengjin Li

    Version of Record online : 24 NOV 2009, DOI: 10.1002/jmri.21769

  19. You have free access to this content
    Nephrogenic systemic fibrosis in liver disease: A systematic review

    Journal of Magnetic Resonance Imaging

    Volume 30, Issue 6, December 2009, Pages: 1313–1322, Sameer M. Mazhar, Masoud Shiehmorteza, Chad A. Kohl, Michael S. Middleton and Claude B. Sirlin

    Version of Record online : 24 NOV 2009, DOI: 10.1002/jmri.21983

  20. Transmetallation and gadolinium: Do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?

    Hemodialysis International

    Volume 14, Issue 3, July 2010, Pages: 289–294, Mandip PANESAR, Frank BOATENG, Sagar S. PATEL, Syed F. MASOOD, Pooja MAHAJAN, Nilang PATEL and Brian MURRAY

    Version of Record online : 19 JUL 2010, DOI: 10.1111/j.1542-4758.2010.00456.x